Stock Forecast

  Koninklijke Philips N.V. ( PHG) Stock. Should you Buy or Sell?    $ 20.53

0.19 (0.92 %)



Koninklijke Philips N.V. Analysis

Updated on 08-08-2022
Symbol PHG
Price $20.53
Beta 0.885
Volume Avg. $1.87 M
Market Cap $18.26 B
52 Week Range $19.69 - $48.72


Koninklijke Philips N.V. opened the day at $20.53 which is +'0.92 % on yesterday's close. Koninklijke Philips N.V. has a 52 week high of $48.72 and 52 week low of $19.69, which is a difference of $29.03. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $18.26 B and total net profit is $17156000000 which means the company is trading at 1.06 times profit to market capitalization. Theoretically, if you were to buy Koninklijke Philips N.V. for $18.26 B, it would take 15 years to get your money back. Koninklijke Philips N.V. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




Koninklijke Philips N.V. Stock Forecast - Is Koninklijke Philips N.V. a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreBuy
PE ScoreStrong Buy
PB ScoreStrong Buy
Overall RecommendationStrong Buy

Growth and Value


PE Ratio 45.622
Dividend Yiel 0.040
Net Profit Margin 0.172


Valuing Koninklijke Philips N.V.


Price Book Value Ratio 1.048 Price To Book Ratio 1.048
Price To Sales Ratio 0.897 Price Earnings Ratio 5.218


How liquid is Koninklijke Philips N.V.


Current Ratio 1.190
Quick Ratio 0.602


Debt


Debt Ratio 0.546 Debt Equity Ratio 1.204
Long Term Debt To Capitalization 0.316 Total Debt To Capitalization 0.352



Latest news about Koninklijke Philips N.V.


Two-Minute Drill: PHG & UCG-IT

Ellen Lee, Causeway Capital portfolio manager, joins ‘Closing Bell Overtime' to discuss her take on Phillips Electronics and UniCredit.

Date : 29/07/2022

Philips' (PHG) Q2 Earnings Down on Supply Chain Constraints

Koninklijke Philips' (PHG) Q2 top and bottom-line results reflect the negative impact of supply chain constraints and COVID lockdowns in China.

Date : 26/07/2022

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q2 2022 Results - Earnings Call Transcript

Koninklijke Philips N.V. (NYSE:PHG ) Q2 2022 Results Conference Call July 25, 2022 4:00 AM ET Company Participants Leandro Mazzoni - Head, IR Frans van Houten - CEO Abhijit Bhattacharya - CFO Roy Jakobs - Chief Business Leader, Connected Care Francis Kim - Chief Quality and Regulatory Officer Conference Call Participants Hassan Al-Wakeel - Barclays David Adlington - JPMorgan Cazenove Julien Dormois - Exane BNP Paribas Graham Doyle - UBS James Vane-Tempest - Jefferies Falko Friedrichs - Deutsche Bank Ed Ridley-Day - Redburn Delphine Le Louet - Societe Generale Leandro Mazzoni Hi, everyone.

Date : 25/07/2022

Philips Stock Sinks on Cut to Sales Guidance

The company says it expects full-year sales growth of 1% to 3%, down from its previous forecast of 3% to 5%.

Date : 25/07/2022

Philips swings to loss and cuts sales guidance

Royal Philips NV PHG, -0.05% PHIA, -9.54% on Monday reported a swing to a net loss for the second quarter, which it blamed on a number of issues including pandemic-related lockdowns in China, inflationary pressures and the Russia-Ukraine war.

Date : 25/07/2022





About Koninklijke Philips N.V.


CEO : Mr. Franois Adrianus van Houten
Sector : Healthcare
Industry : Medical Devices

Website : https://www.philips.com

Exchange : New York Stock Exchange

Description :

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.


My Newsletter

Sign Up For Updates & Newsletters